Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors.

International journal of molecular sciences - 30 Jul 2023

Timofeeva Angelika V, Fedorov Ivan S, Asaturova Aleksandra V, Sannikova Maya V, Tregubova Anna V, Mayboroda Oleg A, Khabas Grigory N, Frankevich Vladimir E, Sukhikh Gennady T

Abstract excerpt

The expression level of the progesterone receptor (PGR) plays a crucial role in determining the biological characteristics of serous ovarian carcinoma. Low PGR expression is associated with chemoresistance and a poorer outcome. In this study, our objective was to explore the relationship between tumor progesterone receptor levels and RNA profiles (miRNAs, piwiRNAs, and mRNAs) to understand their biological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Matrix Metalloproteinase 7
Share to MicroRNAs

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Phenotype

Share to Progesterone

Share to Receptors, Progesterone

Source

Open in PubMed Open full text

Identifiers

PMID: 37569592
DOI: 10.3390/ijms241512214
PMCID: PMC10419267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors.PMID 37569592Read ↗

Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules of Progesterone Receptor-Negative Phenotype of Serous Ovarian TumorsSemantic proximity Read ↗

Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic massSemantic proximity Read ↗

The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian CancerSemantic proximity Read ↗

MicroRNA Signatures in Serous Ovarian Cancer: A Comparison of Prognostic Marker Targets in African Americans and CaucasiansSemantic proximity Read ↗

Exploring the Role of MicroRNAs in Progesterone and Estrogen Receptor Expression in EndometriosisSemantic proximity Read ↗

The circulating miRNA-34a, miRNA -143 and miRNA -212 are promising biomarkers in ovarian cancerSemantic proximity Read ↗

The Role of miRNAs 340‐5p, 92a‐3p, and 381‐3p in Patients with Endometriosis: A Plasma and Mesenchymal Stem‐Like Cell StudySemantic proximity Read ↗

Three plasma-based microRNAs as potent diagnostic biomarkers for endometrial cancerSemantic proximity Read ↗

Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancerSemantic proximity Read ↗

Plasma miRNAs as biomarkers for endometriosisSemantic proximity Read ↗

hsa-miRNA-154-5p expression in plasma of endometriosis patients is a potential diagnostic marker for the diseaseSemantic proximity Read ↗

MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.